Vijayakanth Pagadala

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Venues

Science translational medicine

RSC chemical biology

Science advances

Chemical science

Glycan Therapeutics llc.,

Rosalind Franklin University of Medicine and Science Chicago Medical School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Glycan Therapeutics llc.,

United States

Principal Investigator-Scientist

University of North Carolina at Chapel Hill Nov 11 2013

United States

Post Doctoral Fellow :: School of Pharmacy- Chemical Biology and Medicinal Chemistry

National Institute of Environmental Health Sciences - Nov 10 2013

United States

Post Doctoral Fellow :: Laboratory of Neurobiology- Signal Transduction group

Education History

Rosalind Franklin University of Medicine and Science Chicago Medical School Jun 01 2003 - Jun 01 2009

United States

PHD :: Biochemistry and Molecular Biology

Panjab University

India

MSC :: Biotechnology

Publications

Zhangjie Wang, Vaishali N Patel, Xuehong Song, Yongmei Xu, Andrea M Kaminski, Vivien Uyen Doan, Guowei Su, Yi-En Liao, Dylan Mah, Fuming Zhang, Vijayakanth Pagadala, Chunyu Wang, Lars C Pedersen, Lianchun Wang, Matthew P Hoffman, Marla Gearing, Katelyn Arnold
Increased 3- O -sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene HS3ST1 . Science advances 9 (21) (2023)
Lin Yi, Yongmei Xu, Andrea M Kaminski, Xiaobing Chang, Vijayakanth Pagadala, Maurice Horton, Guowei Su, Zhangjie Wang, Genmin Lu, Pamela Conley, Zhenqing Zhang, Lars C Pedersen, Katelyn Arnold
Using engineered 6-O-sulfotransferase to improve the synthesis of anticoagulant heparin. Organic & biomolecular chemistry 18 (40) (2022)
Rylee Wander, Andrea M Kaminski, Yongmei Xu, Vijayakanth Pagadala, Juno M Krahn, Truong Quang Pham, Katelyn Arnold, Lars C Pedersen
Deciphering the substrate recognition mechanisms of the heparan sulfate 3-O-sulfotransferase-3. RSC chemical biology 2 (4) (2021)
Katelyn Arnold, Yongmei Xu, Erica M Sparkenbaugh, Miaomiao Li, Xiaorui Han, Xing Zhang, Ke Xia, Mark Piegore, Fuming Zhang, Xiaoxiao Zhang, Mike Henderson, Vijayakanth Pagadala, Guowei Su, Lisi Tan, Pyong Woo Park, Richard T Stravitz, Nigel S Key, Robert J Linhardt, Rafal Pawlinski, Ding Xu, Katelyn Arnold
Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure. Science translational medicine 12 (535) (2021)
Zhangjie Wang, Katelyn Arnold, Yongmei Xu, Vijayakanth Pagadala, Guowei Su, Hannah Myatt, Robert J Linhardt, Katelyn Arnold
Quantitative analysis of heparan sulfate using isotopically labeled calibrants. Communications biology 3 (1) (2020)
Yongmei Xu, Kasemsiri Chandarajoti, Xing Zhang, Vijayakanth Pagadala, Wenfang Dou, Debra Moorman Hoppensteadt, Erica M Sparkenbaugh, Brian Cooley, Sharon Daily, Nigel S Key, Diana Severynse-Stevens, Jawed Fareed, Robert J Linhardt, Rafal Pawlinski, Katelyn Arnold
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins. Science translational medicine 9 (406) (2018)
Xing Zhang, Vijayakanth Pagadala, Hannah M Jester, Andrew M Lim, Truong Quang Pham, Anna Marie P Goulas, Jian Liu, Robert J Linhardt
Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: paving the way to a diverse library for glycobiologists. Chemical science 8 (12) (2017)

Vijayakanth Pagadala.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vijayakanth Pagadala